Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier:
NCT01104025
First received: April 13, 2010
Last updated: June 9, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)